Intensity-Modulated Radiation Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
(University of Texas M. D. Anderson Cancer Center) An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer has shown that those who received intensity modulated radiation therapy had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-D conformal radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2015 Category: Cancer & Oncology Source Type: news

High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?
Dr Gerald Chodak talks about the potential role of this treatment approach, alone or in combination with intensity-modulated radiation therapy, in high-risk prostate cancer. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 16, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

A New Treatment Approach for Relapsing Prostate...
IMRT coupled with optimal scanning technology can result in durable remissions and a freedom from dependency on lifelong hormonal therapy. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - October 2, 2015 Category: Cancer & Oncology Tags: health Source Type: news

Seattle Cancer Center Using SMART Mesothelioma Treatment
A Toronto-based groundbreaking approach to treating mesothelioma has crossed the Canadian border and is now part of an innovative Seattle cancer treatment center. Officials at the Swedish Cancer Institute in Seattle recently adopted the Surgery for Mesothelioma After Radiation Therapy (SMART) approach that originated at the Princess Margaret Cancer Center in Toronto. The therapy is a significant shift from the traditional lower-dose, radiation-after-surgery method to a more high-intensity approach that has more than doubled the three-year survival rate for pleural mesothelioma patients. Officials at the Swedish Cance...
Source: Asbestos and Mesothelioma News - July 27, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Extended-field intensity modulated radiation therapy for cervical and endometrial cancers does not increase risk of duodenal toxicity
A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity, scientists report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 7, 2015 Category: Science Source Type: news

Extended-field IMRT does not increase duodenal toxicity risk
(American Society for Radiation Oncology) A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy without increased risk of duodenal toxicity, according to a study published in the July-August 2015 issue of Practical Radiation Oncology, the American Society for Radiation Oncology's journal focused on the clinical practice of radiation oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2015 Category: Cancer & Oncology Source Type: news

First TomoTherapy(R) System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif., Feb. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the first ... Devices, Radiology, OncologyAccuray, TomoTherapy, radiation therapy, IG-IMRT, TomoHelical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 4, 2015 Category: Pharmaceuticals Source Type: news

Improved Radiation Therapy Extends Lives of Mesothelioma Patients
This study gives a definitive edge to the P/D procedure. Median overall survival was 28.4 months for the P/D group compared to just 14.2 months for the EPP group. The progression free survival was 16.4 months for P/D, compared to 8.2 months for the EPP patients. The over survival and progression free survival at the one-year mark for P/D patients was 76 and 67 percent, respectively. It was 56 and 34 percent at two years. For the EPP patients, the overall survival was 55 percent and the progression free survival was 44 percent at one year. Radiation Causes Pulmonary Decline There was one noted downside to the IMRT that has...
Source: Asbestos and Mesothelioma News - December 30, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Acclerated IMRT Comparable to WBI at 5 YearsAcclerated IMRT Comparable to WBI at 5 Years
Outcomes were similar between accelerated partial intensity-modulated radiation therapy (IMRT) and whole breast irridation (WBI), but it may not be worth the extra cost of the technique. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 16, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

In Sinonasal Cancer, New Radiotherapy Trumps Old?In Sinonasal Cancer, New Radiotherapy Trumps Old?
A meta-analysis compares charged-particle, including proton beam, therapy with the more established photon therapy, including IMRT. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 10, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study: Proton beam therapy tops IMRT
Proton beam therapy can provide significantly better disease-free survival (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2014 Category: Radiology Source Type: news

Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
(Mayo Clinic) A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2014 Category: Global & Universal Source Type: news

Proton therapy has advantages over IMRT for advanced head and neck cancers, Mayo study finds
Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world’s literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - July 1, 2014 Category: Research Source Type: news

Gene therapy combined with IMRT reduces rate of positive prostate biopsy after treatment for intermediate-risk prostate cancer patients
Combining oncolytic adenovirus-mediated cytotoxic gene therapy (OAMCGT) with intensity modulated radiation therapy (IMRT) reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients’ quality of life, research has determined. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 2, 2014 Category: Science Source Type: news

Gene therapy combined with IMRT found to reduce recurrence for select prostate cancer patients
(American Society for Radiation Oncology) Combining oncolytic adenovirus-mediated cytotoxic gene therapy with intensity modulated radiation therapy reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients' quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 2, 2014 Category: Cancer & Oncology Source Type: news